Infectious diseases, along with cancers, are among the main causes of death among
humans worldwide. The production of therapeutic proteins for treating diseases at large …

Stationary phases with precisely ordered morphology have the potential to drastically
improve the performance of chromatographic operations, both in the analytical and in the …

Membrane chromatography (MC) is an emerging bioseparation technology combining the
principles of membrane filtration and chromatography. In this process, one type of molecule …

Membrane chromatography is recognised as a potential solution to streamline downstream
processing for protein purification, where ion exchange membrane chromatography (IEMC) …

A high-capacity, multimodal cation exchange (MMC) chromatographic membrane was
developed by conjugating a multimodal ligand–2-mercaptopyridine-3-carboxylic acid …

Protein A chromatography is ubiquitous to antibody purification. The high specificity of
Protein A for binding the Fc-region of antibodies and related products enables unmatched …

Many beneficial proteins have limited natural availability, which often restricts their supply
and thereby reduces their potential for therapeutic or industrial usage. The advent of …

Rapid, convenient methods for monoclonal antibody (mAb) isolation are critical for
determining the concentrations of therapeutic mAbs in human serum. This work uses porous …

The rapid increase in antibody demand is urgently calling for high throughput technologies
to enhance the efficiency in downstream purification. Membrane chromatography using …

Antibodies have become an important class of biological products in cancer treatments such
as radiotherapy. The growing therapeutic applications have driven a demand for high-purity …